Results: UHR pilot: System usage was high, with a total 270 logins (18/ user), 749 posts (58/user), 170 therapy modules completed (12/user), and 67% of users being actively engaged over the trial. All participants reported a positive experience using Momentum and would recommend it to others. 93% considered Momentum to be helpful. Analysis revealed a significant increase in social functioning (p<0.001; d=2.39) and satisfaction with life (p=0.03; d=0.48) at follow-up. There was a significant increase in therapy mechanisms directly targeted by Momentum including strengths usage (p=0.03; d=0.46), mindfulness skills (p=0.04; d=0.36) and components of social support. There were significant correlations between system usage and improvements in social functioning (r=0.63 p=0.02), social support (r=0.62 p=0.02) and strengths usage (r=0.51 p=0.06). FEP pilot: system use was high. The majority of FEP participants reported feeling safe (100%) and more socially connected (60%) using Horyzons. There was a significant reduction (d=0.60; p=0.03) in depressive symptoms at follow-up. FEP RCT: Horyzons' safety outcomes have been consistently strong. System usage is being high, with an average 101 logins, 70 posts, and 11 therapy modules per user, and 60% of users being engaged with the online system for a period of 18 months. Discussion: Horyzons and Momentum are the first online interventions designed to improve functional outcomes in FEP and UHR patients. Momentum is engaging, safe, may improve social functioning and satisfaction with life in UHR patients and appeared to specifically improve therapeutic mechanisms directly targeted by the online intervention. Horyzons is safe and engaging (over prolonged periods of time) and may improve depression and social connectedness in FEP patients. 
Background: Adjunctive psychological interventions as an add-on to pharmacological treatment in serious mental illnesses have shown to further improve long-term outcome, especially in the case of Bipolar Disorder and first episode psychosis. Among them, psychoeducational programs have a well-established evidence of efficacy and cost-efficiency. However, there are several limitations restricting the broad implementation of these psychological treatments, out of which the most important one is related to a tremendous gap between availability and demand. Therefore, there is an emerging interest to explore new approaches to deliver this kind of treatments tailored to individual needs and in a continuous way (e.g. all year long) from any location while maintaining their efficacy at a low cost. The high availability of Internet connected devices as well as it's user-friendly interfaces could be a potential and feasible window to expand and extend psychoeducational programs in Bipolar disorder and other serious mental illnesses. The main objective of this presentation will be: 1. to review the available internet-based psychological interventions for bipolar disorder, 2. to present the SIMPLe project development, studies protocols, results from a feasibility study and an open study, and finally, 3. to provide some insights and perspectives into the future of the field. Methods: A systematic-review of the literature was undertook to review the available internet-based psychological interventions for bipolar disorder and provide a critical appraisal of the studies and platforms included. A feasibility pilot study was conducted to test the first version of the SIMPLe app in which retention, acceptability and satisfaction were assessed in a group of subsequent samples of bipolar patients using the app, pre and post intervention questionnaires and assessments were conducted during face to face interviews. Regarding the open trial (i.e. OpenSIMPLe), a similar approach was adopted, but involving patients from all around the world and using online questionnaires. Results: During the systematic review we identified over 251 potential entries matching the search criteria and after a thorough manual review, 29 publications pertaining to 12 different projects, specifically focusing on psychological interventions for bipolar patients through diverse Internet-based methods, were selected. In the feasibility study, 51 participants were initially enrolled in the study, 36 (74%) remained actively using the application after 3 months. The whole sample interacted with the application a mean of 77 days (SD=26.2). Over 86% of the participants agreed that the experience using the application was satisfactory. So far, the OpenSIMPLe trial have enrolled more than 300 participants, preliminary results show levels of satisfaction beyond 80%, although a retention of only 5% after 6 months was calculated from servers registries. Discussion: Considering the high rates of retention and compliance reported, they represent a potential highly feasible and acceptable method of delivering this kind of interventions to bipolar patients. The results of the feasibility study confirms that this particular intervention is feasible and represent a satisfactory and acceptable instrument for the self-management of bipolar disorder as an add-on to the usual treatment but future clinical trials must still probe its efficacy. Moreover, preliminary results from the OpenSIMPLe study shows that is feasible to extend this intervention to many people at a low cost. Present and future technologies employing passive data collection and weareables could improve the personalization and accuracy of these interventions.
RETHINKING THE TAXONOMY, COURSE, AND OUTCOME OF PSYCHOSES: DIMENSIONAL, LATENT TRAJECTORY, AND TRANSDIAGNOSTIC APPROACHES
William T. Carpenter, Jr.
University of Maryland School of Medicine
Overall Abstract: Evidence continues to accumulate on heterogeneity in phenomenology, course and outcome of non-affective and affective psychotic disorders. Both DSM and ICD classification systems have evolved to include a large number of categories of psychosis. However, doubt remains about this categorical approach because of high comorbidity, common etiological factors and the absence of zones of relative rarity between categorical diagnoses. Some authors have nevertheless argued that categorical representations of psychosis may still be of clinical utility if used in combination with dimensional indicators. It is now widely accepted that psychotic symptoms partition into several symptom dimensions that would support the heterogeneity of psychotic disorders. However, there is no consensus on the exact number of these dimensions, with previous factor-analytic work pointing towards models with two to twelve specific symptom dimensions. However, recently, there has been evidence for a transdiagnostic dimension underlying affective and non-affective psychotic symptoms in schizophrenia, schizoaffective and bipolar disorder that challenges their classification as distinct diagnostic constructs. There is also considerable heterogeneity in clinical course and outcome of psychotic disorders, but how to best map and model this over time remains to be established. Taken together, this presents significant challenges for the classification of psychotic disorders as separate diagnostic entities. This symposium brings together international researchers at the forefront of research into the phenomenology, course and outcome of psychotic disorders. Roman Kotov will present novel data on symptom dimensions and examines the course of these dimensions in an epidemiologic cohort of 628 first-admission inpatients with psychosis interviewed 6 times over two decades in the Suffolk County Mental Health Project. Craig Morgan will report new findings from the 10-year follow-up of the Aetiology and Ethnicity in Schizophrenia and Other Psychoses (AESOP-10) study, an epidemiological cohort of 552 patients with a first episode psychosis, using a data driven approach to identify latent trajectory classes to account for heterogeneity in patterns of change in psychotic symptoms over time and characterize these trajectories with the WHO classification, baseline demographic characteristics and diagnoses. Ulrich Reininghaus will present novel data from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium to investigate whether there is a transdiagnostic dimension cutting across symptoms of schizophrenia, schizoaffective disorder and psychotic bipolar I disorder. Diego Quattrone will report recent findings from EU-GEI Functional Enviromics Study on genetic and socio-environmental factors associated with transdiagnostic and specific symptom dimensions of nonaffective and affective psychosis. Robin Murray will discuss these findings in the context of new challenges in the field and directions for future research.
DIMENSIONS OF PSYCHOSIS AND THEIR TRAJECTORIES DURING TWO DECADES AFTER FIRST HOSPITALIZATION
Roman Kotov* ,1
Stony Brook University
Background: Heterogeneity of psychosis presents significant challenges for classification. Between two and 12 symptom dimensions have been proposed, and consensus is lacking. The present study sought to identify uniquely informative models by comparing the validity of these alternatives. A critical validator is future course, and we examined trajectory of each dimension. Methods: We investigated this question in the first U.S. study to follow an epidemiological cohort with psychotic disorders for 20 years after first hospitalization. Participants were assessed in person 6 times over 2 decades on Global Assessment of Functioning (GAF), psychotic symptoms, and mood symptoms, and 373 completed 20-year follow-up (68% of survivors) including an electrophysiological assessment of error processing. We first analyzed a comprehensive set of 49 symptoms rated by interviewers at baseline, progressively extracting from one to 12 factors. Next, we compared the ability of resulting factor solutions to (a) account for concurrent neural dysfunction and (b) predict 20-year role, social, residential, and global functioning, and life satisfaction. Results: A four-factor model showed incremental validity with all outcomes, and more complex models did not improve explanatory power. The four dimensions-reality distortion, disorganization, inexpressivity, and apathy/asociality-were replicable in 5 follow-ups, internally consistent, stable across assessments, and showed strong discriminant validity. On all of these measures schizophrenia exhibited a decline that began between years 5 and 10. Correspondingly, GAF scores dropped from 49 (Year 4) to 36 (Year 20) . Neither aging nor changes in antipsychotic treatment accounted for the declines. Discussion: These results reaffirm the value of separating disorganization and reality distortion, are consistent with recent findings distinguishing inexpressivity and apathy/asociality, and suggest that these four dimensions are fundamental to understanding neural abnormalities and long-term outcomes in psychosis. They also revealed a substantial symptom burden across psychotic disorders that increased with time and ultimately may undo initial treatment gains. Additional research is needed, but previous studies suggest sociocultural factors and different care models may preempt this decline. Background: The clinical course of psychotic disorders is highly variable. Typically, researchers have captured course types using broad categories, e.g. the WHO instruments to assess course and outcome distinguish three categories: episodic (i.e., no episode > 6 months), continuous (i.e., no remission > 6 months), and neither (i.e., an episode and a remission > 6 months). However, whether these adequately capture symptom trajectories of psychotic disorders has not been assessed. Using AESOP-10 data, we sought to identify classes of individuals with specific symptom trajectories over a 10 year follow up and to, then, compare trajectories with WHO categories and examine associations between trajectories and baseline demographic characteristics and diagnoses. Methods: AESOP-10 is a follow-up, at 10 years, of a cohort of 552 patients with a first episode psychosis identified in south-east London and Nottingham, UK. At follow-up, we collated detailed information on clinical and social course and outcome. This included collating extensive information on month by month fluctuations in presence of psychotic symptoms. Using this data, we fitted growth mixture models to identify latent trajectory classes that accounted for heterogeneity in patterns of change in psychotic symptoms over time.
RETHINKING THE COURSE OF PSYCHOTIC DISORDERS: IDENTIFYING LATENT TRAJECTORIES
Results: We had sufficient data on occurrence of psychotic symptoms throughout the follow up on 326 (~ 60%) patients. A four-class quadratic growth mixture model best fit the data, with four trajectories defined by variations in the mean number of months psychotic per year during the follow-up period: (1) Compared with those with an intermittent trajectory, patients with a persistent trajectory were less often women (OR 0.6, 95% CI 0.4-0.9), more often of black Caribbean ethnicity (OR 2.3, 95% CI 1.2-4.1), and less often had a diagnosis of affective psychosis (OR 0.2, 95% CI 0.1-0.4). There were no differences by age. Numbers were small, but there were indications that those with a late decline trajectory more closely resembled those with a persistent trajectory (i.e., less often women, more often of black Caribbean ethnicity, less often diagnosis of affective psychosis) than did those with a late improvement trajectory. Discussion: Our current approach to classifying course of psychotic disorders may be flawed, particularly in specifying a group as neither episodic nor continuous. Our findings suggest this group is heterogeneous and includes patients whose outcomes more closely resemble one of the two main trajectories, intermittent or persistent. Only a small proportion of patients fit neither. These patients constitute clinically important sub-groups whose trajectories appear to change, either from an initially positive or initially negative course, some years after first contact with mental health services. Our failure to fully characterise trajectories of psychosis may confound efforts to elucidate predictors of long-term outcome. 
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